Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1994-01-25
1996-12-31
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514277, 514640, 514657, 514323, 514469, 514317, 514321, 514252, 514649, A61K 31135, A61K 31435, A61K 3115, A61K 31445
Patent
active
055895123
ABSTRACT:
There is disclosed a method for treating borderline personality disorder in a patient by administering a nontoxic dose of a serotonin re-uptake blocker. Preferably, the serotonin re-uptake blocker is fluoxetine or norfluoxetine.
REFERENCES:
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4626549 (1986-12-01), Molloy et al.
patent: 4647591 (1987-03-01), Cherkin et al.
patent: 4971998 (1990-11-01), Wurtman et al.
Eli Lilly and Co., "Use of fluoxetin or norfluoxetin in treating anxiety," Chem. Abst. 102, 398984, 1985.
Benfeld, et al., "A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness," Chem. Abst. 106, 43304b, 1987.
Cintins Marianne M.
Jarvis William R. A.
LandOfFree
Method for treating borderline personality disorder with seroton does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating borderline personality disorder with seroton, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating borderline personality disorder with seroton will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142539